These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25388645)

  • 21. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study.
    Gao L; Zhang Y; Wang X; Dong H
    BMC Endocr Disord; 2021 Apr; 21(1):59. PubMed ID: 33794863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The difference of lipid profiles between psoriasis with arthritis and psoriasis without arthritis and sex-specific downregulation of methotrexate on the apolipoprotein B/apolipoprotein A-1 ratio.
    Wang B; Deng H; Hu Y; Han L; Huang Q; Fang X; Yang K; Wu S; Zheng Z; Yawalkar N; Zhang Z; Yan K
    Arthritis Res Ther; 2022 Jan; 24(1):17. PubMed ID: 34996506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.
    Öhman M; Öhman ML; Wållberg-Jonsson S
    Scand J Rheumatol; 2014; 43(4):259-64. PubMed ID: 24689997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights of altered lipid profile in Fragile X Syndrome.
    Çaku A; Seidah NG; Lortie A; Gagné N; Perron P; Dubé J; Corbin F
    PLoS One; 2017; 12(3):e0174301. PubMed ID: 28334053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of lipid markers and high-sensitivity C-reactive protein on the value of the 99th percentile upper reference limit for high-sensitivity cardiac troponin I.
    Krintus M; Kozinski M; Fabiszak T; Kuligowska-Prusinska M; Laskowska E; Lennartz L; Nowak-Los L; Kubica J; Sypniewska G
    Clin Chim Acta; 2016 Nov; 462():193-200. PubMed ID: 27693077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
    Wolffenbuttel BH; Franken AA; Vincent HH;
    J Intern Med; 2005 Jun; 257(6):531-9. PubMed ID: 15910557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep duration and abnormal serum lipids: the China Health and Nutrition Survey.
    Zhan Y; Chen R; Yu J
    Sleep Med; 2014 Jul; 15(7):833-9. PubMed ID: 24863406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells.
    Sharma M; Tuaine J; McLaren B; Waters DL; Black K; Jones LM; McCormick SP
    PLoS One; 2016; 11(1):e0148049. PubMed ID: 26807857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins.
    Elshorbagy AK; Valdivia-Garcia M; Graham IM; Palma Reis R; Sales Luis A; Smith AD; Refsum H
    Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1031-8. PubMed ID: 21550220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Apolipoprotein A1, High Density Lipoprotein Cholesterol, and Their Ratio with Inflammatory Marker in Chinese Adults with Coronary Artery Disease.
    Dong H; Wang J; Hu P; Lu N
    Angiology; 2023 Sep; 74(8):765-773. PubMed ID: 36065748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
    Maitra A; Pingle RR; Menon PS; Naik V; Gokral JS; Meherji PK
    Int J Fertil Womens Med; 2001; 46(5):271-7. PubMed ID: 11720200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups.
    Bays HE; Shah A; Lin J; Sisk CM; Dong Q; Maccubbin D
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):197-206. PubMed ID: 22500948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.
    Ghorban K; Shanaki M; Mobarra N; Azad M; Asadi J; Pakzad R; Ehteram H
    Hematology; 2016 Mar; 21(2):113-20. PubMed ID: 25913481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 12 in Takayasu's arteritis: plasma concentrations and relationship with disease activity.
    Verma DK; Tripathy NK; Verma NS; Tiwari S
    J Rheumatol; 2005 Dec; 32(12):2361-3. PubMed ID: 16331764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Serum Lipid Profiles and Early Neurological Deterioration in Acute Ischemic Stroke.
    Ryu WS; Schellingerhout D; Jeong SW; Nahrendorf M; Kim DE
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):2024-30. PubMed ID: 27256172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.